One platform for all researcher needs
AI-powered academic writing assistant
Your #1 AI companion for literature search
AI tool for graphics, illustrations, and artwork
Unlock unlimited use of all AI tools with the Editage Plus membership.
Explore Editage Plus
Audio Papers
Ask R Discovery
Translation
Auto-sync
Collaboration
Open Accesshttps://doi.org/10.1093/annonc/mdz422.074
Copy DOI
Export
Save
Share
Cite Journal: Annals of Oncology |  Publication Date: Nov 1, 2019 |
 Citations: 10 |  License type: publisher-specific-oa |
Affiliation: Japanese Foundation For Cancer Research, National Cancer Center Hospital East, Seoul National University Hospital, University of Chicago, Dana-Farber Cancer Institute, Memorial Sloan Kettering Cancer Center, MedStar Georgetown University Hospital, Leipzig University, Cornell University, Sun Yat-sen University Cancer Center, Astellas Pharma (United States), The University of Texas MD Anderson Cancer Center
198TiP - SPOTLIGHT: Comparison of zolbetuximab or placebo + mFOLFOX6 as first-line treatment in patients with claudin18.2+/HER2– locally advanced unresectable or metastatic gastric or gastroesophageal junction adenocarcinoma (GEJ): A randomized phase III study
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
